Ads
related to: one month free xarelto program applicationscbn.org has been visited by 10K+ users in the past month
dochub.com has been visited by 100K+ users in the past month
Working to be "the most powerful patient advocate in America" - Forbes
singlecare.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]
Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3] The third one edoxaban (Lixiana, Savaysa) was approved in Japan in 2011 and in Europe and the US in 2015. [4]
Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain. [2]
For premium support please call: 800-290-4726 more ways to reach us
Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto drug generated ...
This page was last edited on 20 December 2023, at 19:47 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Ads
related to: one month free xarelto program applicationscbn.org has been visited by 10K+ users in the past month
dochub.com has been visited by 100K+ users in the past month
Working to be "the most powerful patient advocate in America" - Forbes
singlecare.com has been visited by 100K+ users in the past month